Outcomes Associated with Ganciclovir Implants in Patients with AIDS-Related Cytomegalovirus Retinitis

Ophthalmology

Volumn 113, Issue 4, 2006, Pages 673-683.e8

  Kappel, Peter J ^a   Charonis, Alexander C ^a   Holland, Gary N ^a   Narayanan, Raja ^b   Kulkarni, Amol D ^b   Yu, Fei ^a   Boyer, David S ^c   Engstrom Jr , Robert E ^a   Kuppermann, Baruch D ^b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; ANTIVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG IMPLANTATION; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETINA DETACHMENT; RETINITIS; RISK FACTOR; SURGEON; VISUAL ACUITY; VISUAL IMPAIRMENT; ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; CLINICAL TRIAL; DRUG IMPLANT; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PEROPERATIVE COMPLICATION; PHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; DRUG IMPLANTS; FEMALE; GANCICLOVIR; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33645644667     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.11.022     Document Type: Article

References (43)

1. Engstrom Jr. R.E., and Holland G.N. Local therapy for cytomegalovirus retinopathy. Am J Ophthalmol 120 (1995) 376-385
2. Martin D.F., Parks D.J., Mellow S.D., et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol 112 (1994) 1531-1539
3. Musch D.C., Martin D.F., Gordon J.F., et al., Ganciclovir Implant Study Group. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. N Engl J Med 337 (1997) 83-90
4. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 326 (1992) 213-220
5. Kempen J.H., Jabs D.A., Wilson L.A., et al. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis 37 (2003) 1365-1373
6. Holland G.N. New strategies for the management of AIDS-related CMV retinitis in the era of potent antiretroviral therapy. Ocul Immunol Inflamm 7 (1999) 179-188
7. Whitley R.J., Jacobson M.A., Friedberg D.N., et al., International AIDS Society-USA. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy. recommendations of an international panel. Arch Intern Med 158 (1998) 957-969
8. Jabs D.A., Bolton S.G., Dunn J.P., and Palestine A.G. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol 126 (1998) 817-822
9. Vrabec T.R., Baldassano V.F., and Whitcup S.M. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 105 (1998) 1259-1264
10. Martin D.F., Dunn J.P., Davis J.L., et al., International AIDS Society-USA. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy. recommendations of the International AIDS Society-USA panel. Am J Ophthalmol 127 (1999) 329-339
11. Holland G.N., Tufail A., and Jordan M. Cytomegalovirus diseases. In: Pepose J.S., Holland G.N., and Wilhelmus K.R. (Eds). Ocular Infection and Immunity (1996), Mosby, St. Louis 1088-1129
12. Holland G.N., Buhles Jr. W.C., Mastre B., Kaplan H.J., and UCLA CMV Retinopathy Study Group. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. Arch Ophthalmol 107 (1989) 1759-1766
13. Hogan M.J., Kimura S.J., and Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol 47 (1959) 155-170
14. Nussenblatt R.B., Palestine A.G., Chan C.C., and Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92 (1985) 467-471
15. Carpenter C.C., Fischl M.A., Hammer S.M., et al. Antiretroviral therapy for HIV infection in 1998. updated recommendations of the International AIDS Society-USA Panel. JAMA 280 (1998) 78-86
16. Kempen J.H., Jabs D.A., Wilson L.A., et al. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 121 (2003) 466-476
17. Boyer D.S., and Posalski J. Potential complication associated with removal of ganciclovir implants. Am J Ophthalmol 127 (1999) 349-350
18. Davis J.L., Taskintuna I., Freeman W.R., et al. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol 115 (1997) 733-737
19. Nguyen Q.D., Kempen J.H., Bolton S.G., et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 129 (2000) 634-639
20. Dunn J.P., Van Natta M., Foster G., et al., Studies of Ocular Complications of AIDS Research Group. Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis. the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Retina 24 (2004) 41-50
21. Kreiger A.E. The pars plana incision. experimental studies, pathologic observations, and clinical experience. Trans Am Ophthalmol Soc 89 (1991) 549-621
22. Lim J.I., Wolitz R.A., Dowling A.H., et al. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 127 (1999) 288-293
23. Kempen J.H., Jabs D.A., Dunn J.P., et al. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol 119 (2001) 33-40
24. Jabs D.A., Van Natta M.L., Thorne J.E., et al., Studies of Ocular Complications of AIDS Research Group. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. 2. Second eye involvement and retinal detachment. Ophthalmology 111 (2004) 2232-2239
25. Studies of Ocular Complications of AIDS (SOCA) Research Group, AIDS Clinical Trials Group (ACTG). Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. Am J Ophthalmol 124 (1997) 61-70
26. Freeman W.R., Friedberg D.N., Berry C., et al. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 116 (1993) 713-720
27. Sidikaro Y., Silver L., Holland G.N., and Kreiger A.E. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. Ophthalmology 98 (1991) 129-135
28. Davis J.L., Tabandeh H., Feuer W.J., et al. Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with the ganciclovir implant. Am J Ophthalmol 127 (1999) 283-287
29. Shane T.S., Martin D.F., and Endophthalmitis-Gancioclovir Implant Study Group. Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 136 (2003) 649-654
30. Charles N.C., and Freisberg L. Endophthalmitis associated with extrusion of a ganciclovir implant. Am J Ophthalmol 133 (2002) 273-275
31. Tufail A., Weisz J.M., and Holland G.N. Endogenous bacterial endophthalmitis as a complication of intravenous therapy for cytomegalovirus retinopathy. [letter]. Arch Ophthalmol 114 (1996) 879-880
32. Glasgow B.J., Engstrom Jr. R.E., Holland G.N., et al. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol 114 (1996) 873-877
33. Holbrook J.T., Jabs D.A., Weinberg D.V., et al., Studies of Ocular Complications of AIDS (SOCA) Research Group. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 121 (2003) 99-107
34. Martin D.F., Kuppermann B.D., Wolitz R.A., et al., Roche Ganciclovir Study Group. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 340 (1999) 1063-1070
35. Holland G.N., Buhles W.C.J., Mastre B., and Kaplan H.J. CLA CMV Retinopathy Study Group. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. U. Arch Ophthalmol 107 (1989) 1759-1766
36. Holland GN, Tufail A, Jordan M. Cytomegalovirus diseases. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis: Mosby-Year Book; 1996:1088-128.
37. Carpenter C.C., Fischl M.A., Hammer S.M., et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 280 (1998) 78-86
38. Kempen JH, Jabs DA, Wilson LA, et al. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 2003;121:466-76.
39. Nguyen Q.D., Kempen J.H., Bolton S.G., et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 129 (2000) 634-639
40. Musch D.C., Martin D.F., Gordon J.F., et al. Ganciclovir Implant Study Group. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med 337 (1997) 83-90
41. Lim J.I., Wolitz R.A., Dowling A.H., et al. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 127 (1999) 288-293
42. Kempen J.H., Jabs D.A., Dunn J.P., et al. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol 119 (2001) 33-40
43. Jabs D.A., Van Natta M.L., Thorne J.E., et al. Studies of Ocular Complications of AIDS Research Group. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology 111 (2004) 2232-2239